KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
International Journal Of Molecular Sciences
Martianov, Aleksandr S AS; Mitiushkina, Natalia V NV; Ershova, Anastasia N AN; Martynenko, Darya E DE; Bubnov, Mikhail G MG; Amankwah, Priscilla P; Yanus, Grigory A GA; Aleksakhina, Svetlana N SN; Tiurin, Vladislav I VI; Venina, Aigul R AR; Anuskina, Aleksandra A AA; Gorgul, Yuliy A YA; Shestakova, Anna D AD; Maidin, Mikhail A MA; Belyaev, Alexey M AM; Baboshkina, Liliya S LS; Iyevleva, Aglaya G AG; Imyanitov, Evgeny N EN
Acquired resistance to immunotherapy in MMR-D pancreatic cancer.
Journal For Immunotherapy Of Cancer
Hu, Zishuo Ian ZI; Hellmann, Matthew D MD; Wolchok, Jedd D JD; Vyas, Monika M; Shia, Jinru J; Stadler, Zsofia K ZK; Diaz, Luis A LA; O'Reilly, Eileen M EM
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.
Scientific Reports
Simbolo, Michele M; Vicentini, Caterina C; Ruzzenente, Andrea A; Brunelli, Matteo M; Conci, Simone S; Fassan, Matteo M; Mafficini, Andrea A; Rusev, Borislav B; Corbo, Vincenzo V; Capelli, Paola P; Bria, Emilio E; Pedron, Serena S; Turri, Giona G; Lawlor, Rita T RT; Tortora, Giampaolo G; Bassi, Claudio C; Guglielmi, Alfredo A; Scarpa, Aldo A
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.
Bmc Bioinformatics
Melloni, Giorgio E M GE; de Pretis, Stefano S; Riva, Laura L; Pelizzola, Mattia M; Céol, Arnaud A; Costanza, Jole J; Müller, Heiko H; Zammataro, Luca L